The prevalence of multiple endocrine<unk>  type 2 is approximately 2.5 per 100,000  individuals worldwide.  Multiple endocrine<unk>  type 2B manifests in early infancy while multiple endocrine<unk>  type 2A and familial medullary thyroid carcinoma manifest in adulthood.
Multiple endocrine neoplasia type 2 epidemiology and demographics
Multiple endocrine neoplasia type 1 epidemiology and demographics
Multiple endocrine neoplasia type 1 classification
Multiple endocrine neoplasia type 1 pathophysiology
Multiple endocrine neoplasia type 2 pathophysiology
Alstrom syndrome epidemiology and demographics
Autoimmune polyendocrine syndrome epidemiology and demographics
Glucagonoma epidemiology and demographics